On Tuesday (February 27) a public cannabis company with assets in the US decided to switch public exchanges in order to maintain those interests and avoid getting delisted by the TSX Venture.
Maple Leaf Green World (TSXV:MGW) decided it was more important to maintain its operations in the US by voluntary delisting from the TSXV and moving its common shares to the Aequitas NEO Exchange–the same exchange that offers one of the most recent marijuana exchange-traded fund (ETF).
The company was signaled by the TSXV for holding interests in cannabis operations below the Canadian border, where uncertainty rules the regulatory landscape as the drug remains illegal at the federal level. However, several states have introduced legislation policies for marijuana.
Dale Shirley, investor relations for Maple Leaf Green World, told the Investing News Network (INN) he had been responding to calls all morning from curious investors wanting clarification on what the exchange situation means for the company and their shares.
“The US part of our operations is a big piece of the company, so divesting it really was not an option and being delisted would not go over too well with the shareholders,” Shirley said.
TSXV requested Maple Leaf to dump US assets or face delisting
“TSX and TSXV provided clarity regarding the application of our requirements for applicants and existing listed issuers in the marijuana sector in the TSX staff notice and TSXV bulletin issued in October 2017,” a TMX spokesperson told INN. “We continue to welcome qualified applicants in all sectors who are operating in compliance with our exchanges’ requirements, including marijuana companies that operate within Canada and comply with applicable Canadian law.”
In February the company revealed the TSXV exchange sent a notice challenging the validity of the company’s listing because of its assets in Nevada. Maple Leaf contended since the production of cannabis had not yet begun and said that its shares still belonged on the exchange.
The TSXV asked the company to divest the asset or transfer its shares into another exchange that would allow that business.
“[Maple Leaf] is of the view that it is currently in compliance with the Exchange Bulletin and has made a submission to the TSXV clarifying the state of its current operations in the United States,” the company wrote on February 6.
As part of Tuesday’s announcement the company said the NEO exchange offers “an innovative trading venue and a value added listing venue for capital raising companies and investment products.”
Maple Leaf expects the exchange switch to take place by the end of March pending meeting the conditions from both exchanges.
A representative from NEO told INN the exchange confirmed the information shared by Maple Leaf. However, it could not provide any other comments at this stage of the process.
Last year Aphria (TSX:APH; OTC:APHQF) held a similar dispute with the exchange for their interest in the US by having a stake in an Arizona producer and Liberty Health Sciences (CSE:LHS), a Canadian company operating cannabis businesses in the US.
After months of back and forth between the company and the TMX Group, Aphria finally announced it would dump its US assets.
Maple Leaf closed Monday’s (February 26) trading period with a share price of $0.94. By Tuesday the stock was losing value early. As of 11:00 a.m. EST, the company’s share price dropped to $0.75, the lowest value the stock has seen this year.
That said, so far this year, Maple Leaf’s shareholders have seen positive returns, with an 8 percent increase year-to-date. By the closing time in the public markets, the share price for Maple Leaf had decreased 13.83 percent since Tuesday’s open representing a loss of $0.13 per share.
In an attempt to clear the situation for its shareholders, Maple Leaf issued a statement on Wednesday (February 28) to clarify its reasoning for leaving the TSXV.
“In management of the company’s view, the NEO Exchange has an exceptional focus on understanding and helping meet the needs of public companies,” Maple Leaf said.
The company called the switch in exchanges an important milestone for its progress. According to Maple Leaf, the NEO has a simple value proposition for them that attracted them.
“As a company deeply entrenched in the North American cannabis sector, it was important for management of the Company to select to partner with an exchange that has clear views on where it stands in relation to the industry,” Maple Leaf explained.
Early on Wednesday, the company has seen a bounceback for its share price. As of 12:30 p.m. EST Maple Leaf’s stock has gone up 2.47 percent since the markets opened, returning its price per share back to $0.83 cents.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
Editor’s Note: This article was updated on February 28 to include new information provided by Maple Leaf Green World.
Editorial Disclosure: Maple Leaf Green World is a client of the Investing News Network. This article is not paid-for content.
Meanwhile, two longstanding cannabis partners ended their relationship.
Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development
Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.
The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 with Planned Completion and Emergency Use Authorization Request
Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.
With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.
HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.
DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.